Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Shuttle Pharmaceuticals (SHPH)

Annual Return

Over the past 3 years, SHPH has had an average annual return of -84.75%, underperforming the benchmark SPY, which returned +22.77% annual.

Since Aug 31, 2022, SHPH has had an average annual return of -91.39%, underperforming the benchmark SPY, which returned +20.63% annual.

20262025202420232022
-50.00%-92.86%-76.27%-76.82%-94.91%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2026+50%-66.67%+0%+0%+0%+0%-50.00%
2025-14.29%-16.67%-35.00%-30.77%-33.33%-16.67%+0%-20.00%+25%-20.00%-50.00%+0%-92.86%
2024-14.41%+0.99%+3.92%-0%+30.19%-24.64%+0%-39.42%-31.75%+41.86%-54.10%-0%-76.27%
2023-5.11%+1.24%-29.24%+23.99%-32.63%+3.46%-21.74%-17.95%-17.19%-23.27%+6.56%-9.23%-76.82%
2022+0%-88.07%-42.92%-44.64%+35.01%-94.91%

Drawdown analysis of Shuttle Pharmaceuticals (SHPH)

The maximum drawdown for the SHPH was -99.99%, occurring on Feb 11, 2026. This drawdown has not yet recovered.

The current SHPH drawdown is -99.99%.

Since Aug 31, 2022 SHPH has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-99.99%Sep 1, 2022863Feb 11, 2026OngoingOngoingOngoing